A detailed history of Mjp Associates Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Mjp Associates Inc holds 8,590 shares of EW stock, worth $588,586. This represents 0.16% of its overall portfolio holdings.

Number of Shares
8,590
Previous 8,250 4.12%
Holding current value
$588,586
Previous $788,000 0.63%
% of portfolio
0.16%
Previous 0.17%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$84.3 - $94.31 $28,662 - $32,065
340 Added 4.12%
8,590 $793,000
Q1 2024

Apr 11, 2024

BUY
$72.54 - $95.56 $150,520 - $198,287
2,075 Added 33.6%
8,250 $788,000
Q4 2023

Jan 18, 2024

BUY
$61.71 - $77.76 $5,121 - $6,454
83 Added 1.36%
6,175 $470,000
Q3 2023

Oct 10, 2023

BUY
$69.28 - $93.38 $20,437 - $27,547
295 Added 5.09%
6,092 $422,000
Q2 2023

Jul 11, 2023

BUY
$81.41 - $94.33 $62,115 - $71,973
763 Added 15.16%
5,797 $546,000
Q1 2023

Apr 17, 2023

BUY
$74.26 - $84.51 $24,431 - $27,803
329 Added 6.99%
5,034 $416,000
Q4 2022

Jan 20, 2023

BUY
$68.3 - $87.44 $11,679 - $14,952
171 Added 3.77%
4,705 $0
Q3 2022

Oct 12, 2022

SELL
$82.37 - $107.29 $9,554 - $12,445
-116 Reduced 2.49%
4,534 $375,000
Q2 2022

Jul 11, 2022

SELL
$86.5 - $128.27 $29,323 - $43,483
-339 Reduced 6.79%
4,650 $442,000
Q1 2022

Apr 19, 2022

SELL
$101.96 - $128.34 $41,701 - $52,491
-409 Reduced 7.58%
4,989 $587,000
Q4 2021

Jan 18, 2022

BUY
$106.37 - $130.68 $97,966 - $120,356
921 Added 20.57%
5,398 $693,000
Q3 2021

Oct 13, 2021

BUY
$102.91 - $122.75 $5,660 - $6,751
55 Added 1.24%
4,477 $507,000
Q2 2021

Jul 14, 2021

SELL
$83.84 - $104.76 $3,521 - $4,399
-42 Reduced 0.94%
4,422 $458,000
Q1 2021

May 04, 2021

BUY
$78.68 - $90.67 $29,662 - $34,182
377 Added 9.22%
4,464 $373,000
Q4 2020

Jan 27, 2021

BUY
$71.69 - $91.23 $292,997 - $372,857
4,087 New
4,087 $373,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $42.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Mjp Associates Inc Portfolio

Follow Mjp Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mjp Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mjp Associates Inc with notifications on news.